'Creating Companies That Work' Will Be the Topic of Discussion of a Panel of Medical Device Entrepreneurs at Medtech Insight's 'Investment In Innovation -In3-: A Preview of Early-Stage Medical Technology Companies' Conference Next Week in San Francisco.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- June 14-15, 2005, San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden Medtech Insight has announced that its upcoming "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference June 14-15 at The Palace Hotel in San Francisco will feature an insightful and interactive industry panel discussion titled "The State of the Medical Device Industry: 2005 and Beyond." The panel, which will conclude the presentations by nearly 50 medical device startups, will discuss a variety of topics including: financing strategies: what's new, what's not; adoption issues: making sure physicians want and need your product; operational issues: creating companies that work, and work well; and exit strategies: what's the best choice for your company. Panelists will include Scott Schorer, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Innovative Spinal Technologies; Frank M. Fischer, president and CEO of NeuroPace; Frederic H. Moll, founder and CEO of Hansen Medical; and Kevin Sidow, president and CEO of St. Francis Medical Technologies. The panel will be moderated by David Cassak, managing partner at Windhover wind·hov·er n. Chiefly British A kestrel. Information. "The path to success for medical device companies is rarely straight and there are as many different roads to success as there are common ones," said Cassak. "In this panel, a distinguished group of device executives will talk about the opportunities that stood before them, the challenges they faced and obstacles they overcame in building highly successful companies." This conference will showcase presentations by nearly 50 promising early-stage medical technology companies seeking funding, acquisition, or strategic partnership. These emerging companies (most presenting at an In3 event for the first time) are developing a variety of innovative new technologies for such high-growth market segments of the medical device market including cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease diagnosis and treatment, cancer detection and treatment, orthopedics, diabetes and wound management, urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. , surgical visualization, and imaging, among many others. They will present to an audience of over 350 senior executives representing the top investment and medical technology firms. The forum will include focused 10-minute presentations by a senior executive from each presenting company, followed immediately by one-on-one meetings with company representatives in private breakout rooms. Companies confirmed to present include (with more being added prior to the event): Advanced BioSensors, Aeres Medical, Affinergy, Alpine Biomed, Anpa Medical, Aperio Technologies, Apogee apogee (ăp`əjē), point farthest from the earth in the orbit of a body about the earth. See apsis. The farthest point. Biodimensions, Aqueduct Medical, Arbor Surgical Technologies, Bioheart, Biomarker Technologies, Cardiac Power, CardioFocus, CoAxia, CoolTouch, FlowCardia, Grant Life Sciences, Harbinger Medical, Hoana Medical, HydroCision, Intelligent Clothing, Interventional Imaging, IYIA Technologies, LabNow, Maxwell Sensors, MedicalCV, Micro Vision Systems, Minnow minnow, common name for the Cyprinidae, a large family of freshwater fish which includes the carp (Cyprinus carpio), and of which there are some 300 American species. The European minnow is Phoxinus phoxinus. Medical, MINVASYS, Mitralign, Mogul Enterprises, Nano Interface Technology, Neural Intervention Technologies, NeuroVision, Oculus oculus (Latin: “eye”) In architecture, any of several elements resembling an eye, such as a round or oval window or the round opening at the top of some domes (see Pantheon). Innovative Sciences, PlaCor, QuiCare, Remote Clinical Solutions, Smart Medical Technologies, Spine Motion, SPL (1) (Systems Programming Language) The assembly language for the HP 3000 series. See assembly language for an SPL program example. (2) (Structured Programming Language) See structured programming. 1. Development, TechniScan Medical Systems, Vascular Designs, Viking Systems, Visionsense, Xilas Medical, and Xillix Technologies. Check the Medtech Insight Web site at http://www.medtechinsight.com/in3-14.html for a regularly updated listing of presenters, their technology descriptions, and other event details. The conference will be kicked off by keynote presentations by industry veterans Jay Watkins, managing director at De Novo [Latin, Anew.] A second time; afresh. A trial or a hearing that is ordered by an appellate court that has reviewed the record of a hearing in a lower court and sent the matter back to the original court for a new trial, as if it had not been previously heard nor decided. Ventures, who will speak on "Medical Technology Investing: Perspectives of a VC," and Rodney Perkins, M.D., founder, chairman & CEO of Sound ID, who will discuss "Lessons Learned from a Serial Entrepreneur Serial entrepreneur Business person that successfully starts (does not kill) a number of different businesses. ." Ronald Podraza, CEO of Reimbursement Principles, will also speak at the meeting about "Reimbursement Issues Throughout the Device Lifecycle," and Robin M. Silva, partner at Dorsey & Whitney, will present on "Making Your IP Work for You: What Every Medtech Company Needs to Know About Starting, Managing, and Leveraging Your IP Portfolios." See the conference agenda for more information: http://www.medtechinsight.com/Agenda-in3-14.html. Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for senior executives in the medical device, diagnostics, biotech, pharmaceutical and investment communities to preview promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. To register to attend In3 San Francisco, call Kristy Grimes Grimes is a surname, that is believed to be of a Scandinavian decent and may refer to
About Medtech Insight Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion